Additionally, we found associations of the serum Cat S levels with the GC patients’ tumor sizes, lymph node stages and distant metastases; i.e., more advanced TNM stages were associated with higher levels of serum Cat S. To further define the clinical importance of Cat S, we investigated the correlation between Cat S expression and the overall survival of the GC patients. This evidence concerns the gene CAT and neoplasm.